middl
east
respiratori
syndrom
coronaviru
merscov
emerg
viru
first
report
human
june
date
merscov
continu
infect
human
fatal
rate
least
countri
report
human
infect
merscov
http
wwwwhointemergenciesmerscoven
merscov
zoonot
viru
like
sever
acut
respiratori
syndrom
coronaviru
sarscov
merscov
believ
origin
bat
howev
wherea
battohuman
transmiss
sarscov
like
mediat
palm
civet
intermedi
host
human
like
acquir
merscov
dromedari
camel
humantohuman
transmiss
merscov
occur
limit
mostli
health
care
environ
moreov
wherea
sarscov
recogn
angiotensinconvert
enzym
cellular
receptor
merscov
use
dipeptidyl
peptidas
enter
target
cell
current
vaccin
antivir
therapeut
approv
prevent
treatment
merscov
infect
although
number
develop
preclin
andor
test
clinic
articl
special
issu
virus
written
research
work
merscov
field
main
aim
issu
better
understand
merscov
transmiss
epidemiolog
pathogenesi
ii
summar
current
progress
merscov
anim
model
vaccin
therapeut
iii
discuss
futur
prospect
merscov
research
issu
includ
seven
review
articl
nine
origin
research
paper
provid
detail
updat
current
merscov
studi
studi
transmiss
epidemiolog
pathogenesi
merscov
form
one
foundat
merscov
research
issu
farag
colleagu
summar
possibl
driver
emerg
merscov
spillov
human
qatar
explain
potenti
reason
cameltohuman
transmiss
merscov
review
articl
song
colleagu
provid
overal
descript
epidemiolog
pathogenesi
import
aspect
merscov
widagdo
colleagu
review
host
determin
transmiss
pathogenesi
merscov
indic
receptor
play
import
role
process
research
articl
yan
colleagu
character
role
lipid
profil
pathogenesi
infect
human
coronavirus
includ
merscov
suggest
lipid
metabol
may
involv
propag
coronavirus
report
provid
insight
merscov
infect
cell
spread
within
across
host
speci
also
laid
foundat
develop
anim
model
anim
model
essenti
tool
preclin
evalu
antimerscov
countermeasur
dromedari
camel
alpaca
nonhuman
primat
suscept
merscov
infect
howev
viru
infect
small
anim
mice
hamster
ferret
sever
mous
model
express
human
establish
merscov
infect
issu
widagdo
colleagu
examin
rabbit
potenti
host
merscov
show
merscov
infect
rabbit
without
caus
symptom
also
analyz
rout
merscov
transmiss
rabbit
fan
colleagu
report
develop
mous
model
insert
gene
constitut
ubiquit
gene
express
locu
use
technolog
mous
model
suscept
merscov
infect
articl
establish
platform
test
vaccin
therapeut
agent
target
merscov
effect
vaccin
essenti
prevent
merscov
infect
merscov
surfac
spike
protein
key
target
vaccin
design
protein
compris
two
subunit
subunit
respons
bind
receptor
via
receptorbind
domain
rbd
subunit
mediat
membran
fusion
sever
merscov
proteinbas
vaccin
develop
test
anim
model
show
protect
efficaci
merscov
issu
schindewolf
menacheri
summar
progress
merscov
sproteinbas
vaccin
develop
also
describ
potenti
challeng
zhou
colleagu
review
current
advanc
rbdbase
merscov
vaccin
research
paper
adney
colleagu
evalu
efficaci
merscov
subunit
vaccin
aid
adjuv
author
report
reduc
delay
viral
shed
dromedari
camel
well
complet
protect
alpaca
merscov
infect
studi
demonstr
protect
efficaci
mer
vaccin
posit
correl
neutral
antibodi
titer
serum
addit
induc
neutral
antibodi
type
vaccin
induc
cellular
immun
respons
merscov
protein
structur
protein
nucleocapsid
n
protein
may
also
serv
vaccin
target
veit
colleagu
report
merscov
n
proteinbas
vaccin
deliv
modifi
vaccinia
viru
induc
cell
respons
mous
model
identifi
merscov
n
proteinspecif
cell
epitop
vaccin
overal
report
demonstr
varieti
promis
vaccin
tool
avail
prevent
merscov
infect
human
anim
therapeut
critic
tool
treat
merscov
infect
merscov
protein
import
target
therapeut
develop
merscov
contain
two
heptad
repeat
region
critic
proteinmedi
membran
fusion
henc
peptid
mimick
may
interfer
viral
membranefus
process
moreov
rbdtarget
neutral
monoclon
antibodi
mab
block
viral
attach
step
addit
convent
mab
singledomain
antibodi
isol
camelid
call
nanobodi
nb
also
block
rbdreceptor
interact
nb
gain
popular
therapeut
agent
due
small
size
high
stabil
thu
peptid
mimic
rbdtarget
mab
nb
may
serv
merscov
entri
inhibitor
furthermor
small
molecul
target
protein
nonstructur
protein
may
serv
therapeut
altern
peptid
mimic
antibodi
issu
two
review
articl
report
current
advanc
therapeut
neutral
antibodi
one
han
colleagu
zhou
colleagu
latter
articl
also
discuss
potenti
strategi
challeng
improv
efficaci
therapeut
neutral
antibodi
research
articl
colleagu
describ
construct
express
dimer
trimer
nb
target
merscov
rbd
demonstr
strong
stabil
high
neutral
activ
nb
multipl
merscov
strain
anoth
research
articl
xia
colleagu
report
three
peptid
mimick
mersrel
coronaviru
bat
strongli
inhibit
merscov
infect
interestingli
wang
colleagu
report
combin
merscov
peptid
mimic
rbdtarget
neutral
mab
demonstr
potent
synergist
effect
inhibit
merscov
proteinmedi
viral
entri
anoth
research
articl
jiang
colleagu
report
antibodi
target
complement
receptor
inhibit
merscov
infect
indic
merscov
infect
elicit
overactiv
complement
system
process
block
antibodi
moreov
liang
colleagu
review
advanc
develop
smallmolecular
merscov
inhibitor
overal
articl
confirm
antimerscov
therapeut
great
potenti
treat
merscov
infect
human
anim
summar
signific
progress
made
merscov
research
past
seven
year
sinc
viru
discov
progress
includ
limit
epidemiolog
transmiss
pathogenesi
merscov
well
anim
model
vaccin
antivir
merscov
special
issu
virus
provid
updat
report
progress
howev
challeng
remain
exampl
still
understand
exactli
merscov
transmit
bat
camel
human
moreov
compar
hiv
influenza
virus
potenti
market
merscov
vaccin
therapeut
much
smaller
make
commerci
mersrel
product
challeng
nevertheless
past
two
decad
wit
emerg
two
highli
pathogen
coronavirus
merscov
sarscov
two
virus
remain
signific
threat
global
health
futur
novel
coronavirus
pandem
potenti
may
emerg
anim
reservoir
infect
human
thu
research
merscov
remain
high
prioriti
virolog
commun
fact
impress
progress
merscov
research
benefit
tremend
previou
research
coronavirus
includ
sarscov
therefor
scientist
current
effort
regard
merscov
prepar
human
battl
futur
novel
coronavirus
pandem
potenti
